Lyra Therapeutics CEO Maria Palasis' 2020 pay jumps 410% to $4.3M
Lyra Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 14, 2021
Lyra Therapeutics reported fiscal year 2020 executive compensation information on April 14, 2021.
In 2020, three executives at Lyra Therapeutics received on average a compensation package of $1.9M, a 137% increase compared to previous year.
Average pay of disclosed executives at Lyra Therapeutics
Maria Palasis, Chief Executive Officer, received $4.3M in total, which increased by 410% compared to 2019. 82% of Palasis' compensation, or $3.5M, was in option awards. Palasis also received $275K in non-equity incentive plan, $471K in salary, as well as $8.6K in other compensation.
R. Don Elsey, Chief Financial Officer, received a compensation package of $761K, which increased by 3% compared to previous year. 48% of the compensation package, or $363K, was in salary.
Robert Richard, Senior Vice President of Research and Development, earned $550K in 2020.
Related executives
You may also like
Source: SEC filing on April 14, 2021.